Hound Partners’s Freeline Therapeutics Holdings FRLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-4,667
Closed -$1.09M – 145
2020
Q3
$1.09M Buy
+4,667
New +$1.17M 0.07% 84

Other funds holding FRLN

Hound Partners's FRLN Position: Q4 2020 in Review

Hound Partners sold out of Freeline Therapeutics Holdings (FRLN) in Q4 2020, closing a stake of 4,667 shares — an estimated $1.09M sold.

Hound Partners first reported a position in FRLN in Q3 2020 and held it in 1 quarter. The position peaked at $1.09M in Q3 2020. 20 funds tracked by Wall St. Rank hold FRLN as of Q4 2020.

  • Hound Partners reported no remaining Freeline Therapeutics Holdings position as of Q4 2020 after selling out during the quarter.
  • Hound Partners sold 4,667 Freeline Therapeutics Holdings shares in Q4 2020, an estimated $1.09M.
  • Hound Partners first reported a position in Freeline Therapeutics Holdings in Q3 2020 and held it in 1 quarter.
  • Hound Partners's Freeline Therapeutics Holdings position peaked at $1.09M in Q3 2020.
  • 20 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings as of Q4 2020.

Based on Hound Partners's 13F filing for Q4 2020, filed 16 Feb 2021.